AC
Accustem Sciences Inc.
ACUT · OTC
$0.16 +22.89% (+$0.03)
1M -11.43%
Market Cap $1.93M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.19
18.8% upside
Trenutna cena
$0.16
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ACUT trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 19.60x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
FCF margin 1,224.39%
Net margin 1,680.03%
Quality
58 /100
Average ROIC 43.20%
Asset turnover 0.06x
ROA 102.92%
Debt
0 /100
High Current ratio 0.02x
Debt/Equity N/A
Debt/Assets N/A
Stability
39 /100
Moderate Beta 1.87x
Profitable years 0
EPS volatility 19.68%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ACUT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Wendy E. Blosser
Employees
4
Headquarters
New York City